We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Lipid Profile of Tenon's Capsule

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01021657
Recruitment Status : Completed
First Posted : November 30, 2009
Last Update Posted : November 30, 2009
Sponsor:
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to provide data on the lipid profile of the Tenon's capsule in Human glaucomatous eyes and to establish possible relationships with the short term outcome of filtration surgery.

Condition or disease Intervention/treatment
Glaucoma Procedure: trabeculectomies, non penetrating deep sclerectomies

Study Design

Study Type : Observational
Actual Enrollment : 27 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Lipid Profile of Tenon's Capsule in Glaucoma Patients
Study Start Date : January 2009
Primary Completion Date : June 2009
Study Completion Date : June 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Glaucoma
U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
Glaucoma Procedure: trabeculectomies, non penetrating deep sclerectomies


Outcome Measures

Primary Outcome Measures :
  1. To provide data on the lipid profile of the Tenon's capsule in Human glaucomatous eyes and to establish possible relationships with the short term outcome of filtration surgery. [ Time Frame: 6 month later ]

Biospecimen Retention:   Samples Without DNA
Eye Tenon's Capsule

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient suffering from Glaucoma
Criteria

Inclusion Criteria:

  • Glaucoma
  • Eligibility for surgery

Exclusion Criteria:

  • Patients without Glaucoma
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01021657


Locations
France
Ophthalmology Unit CHU Dijon
Dijon, France, 21000
Sponsors and Collaborators
Centre Hospitalier Universitaire Dijon
Investigators
Principal Investigator: Catherine Creuzot-Gracher, MD, PhD Ophthalmology unit CHU Dijon
More Information

Responsible Party: Professor Catherine Creuzot-Garcher, Ophthalmology Department
ClinicalTrials.gov Identifier: NCT01021657     History of Changes
Other Study ID Numbers: Alain01
First Posted: November 30, 2009    Key Record Dates
Last Update Posted: November 30, 2009
Last Verified: November 2009

Keywords provided by Centre Hospitalier Universitaire Dijon:
Glaucoma
Tenon's Capsule
Lipid profile
Assessment of lipid profile in Tenon's capsule in patients with Glaucoma

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases